Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Is octreotide beneficial in patients undergoing pancreaticoduodenectomy? Best evidence topic (BET).

Drymousis P, Pai M, Spalding D, Jiao LR, Habib N, Zacharakis E.

Int J Surg. 2013;11(9):779-82. doi: 10.1016/j.ijsu.2013.06.013. Epub 2013 Jun 22. Review.

2.

Somatostatin analogues for pancreatic surgery.

Gurusamy KS, Koti R, Fusai G, Davidson BR.

Cochrane Database Syst Rev. 2012 Jun 13;(6):CD008370. doi: 10.1002/14651858.CD008370.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;(4):CD008370.

PMID:
22696379
3.

Somatostatin analogues for pancreatic surgery.

Gurusamy KS, Koti R, Fusai G, Davidson BR.

Cochrane Database Syst Rev. 2013 Apr 30;(4):CD008370. doi: 10.1002/14651858.CD008370.pub3. Review.

PMID:
23633353
4.

Meta-analysis of randomized controlled trials on the effectiveness of somatostatin analogues for pancreatic surgery: a Cochrane review.

Koti RS, Gurusamy KS, Fusai G, Davidson BR.

HPB (Oxford). 2010 Apr;12(3):155-65. doi: 10.1111/j.1477-2574.2010.00157.x. Review.

5.

Somatostatin analogues for pancreatic surgery.

Gurusamy KS, Koti R, Fusai G, Davidson BR.

Cochrane Database Syst Rev. 2010 Feb 17;(2):CD008370. doi: 10.1002/14651858.CD008370. Review. Update in: Cochrane Database Syst Rev. 2012;6:CD008370.

PMID:
20166101
7.

Pancreatic surgical complications--the case for prophylaxis.

Gouillat C, Gigot JF.

Gut. 2001 Dec;49 Suppl 4:iv32-9. Review.

8.

Measures to prevent pancreatic fistula after pancreatoduodenectomy: a comprehensive review.

Lai EC, Lau SH, Lau WY.

Arch Surg. 2009 Nov;144(11):1074-80. doi: 10.1001/archsurg.2009.193. Review.

PMID:
19917946
9.

Systematic review and meta-analysis of somatostatin analogues in the prevention of postoperative complication after pancreaticoduodenectomy.

Jin K, Zhou H, Zhang J, Wang W, Sun Y, Ruan C, Hu Z, Wang Y.

Dig Surg. 2015;32(3):196-207. Review.

10.

Efficacy of somatostatin and its analogues in prevention of postoperative complications after pancreaticoduodenectomy: a meta-analysis of randomized controlled trials.

Zeng Q, Zhang Q, Han S, Yu Z, Zheng M, Zhou M, Bai J, Jin R.

Pancreas. 2008 Jan;36(1):18-25. doi: 10.1097/mpa.0b013e3181343f5d.

PMID:
18192875
11.

Prophylactic octreotide and delayed gastric emptying after pancreaticoduodenectomy: results of a prospective randomized double-blinded placebo-controlled trial.

Kollmar O, Moussavian MR, Richter S, de Roi P, Maurer CA, Schilling MK.

Eur J Surg Oncol. 2008 Aug;34(8):868-75. doi: 10.1016/j.ejso.2008.01.014. Epub 2008 Mar 4.

PMID:
18299182
12.
13.

Octreotide prophylaxis is not beneficial for biochemical activity and clinical severity of postoperative pancreatic fistula after pancreatic surgery.

Droeser RA, Jeanmonod P, Schuld J, Moussavian MR, Schilling MK, Kollmar O.

Dig Surg. 2012;29(6):484-91. doi: 10.1159/000345874. Epub 2013 Jan 31.

14.

[Pancreaticojejunal anastomosis: the "Achilles heel" of pancreaticoduodenectomy].

Gulbinas A, Barauskas G, Pundzius J.

Medicina (Kaunas). 2004;40(10):927-34. Review. Lithuanian.

15.

Prevention of pancreatic anastomotic leakage after pancreaticoduodenectomy.

Poon RT, Lo SH, Fong D, Fan ST, Wong J.

Am J Surg. 2002 Jan;183(1):42-52.

PMID:
11869701
16.

Octreotide does not prevent postoperative pancreatic fistula or mortality following Pancreaticoduodenectomy.

Barnett SP, Hodul PJ, Creech S, Pickleman J, Arahna GV.

Am Surg. 2004 Mar;70(3):222-6; discussion 227.

PMID:
15055845
17.

Selective administration of prophylactic octreotide during pancreaticoduodenectomy: a clinical and cost-benefit analysis in low- and high-risk glands.

Vanounou T, Pratt WB, Callery MP, Vollmer CM Jr.

J Am Coll Surg. 2007 Oct;205(4):546-57. Epub 2007 Aug 23.

PMID:
17903728
18.

An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma.

Stojadinovic A, Brooks A, Hoos A, Jaques DP, Conlon KC, Brennan MF.

J Am Coll Surg. 2003 Jun;196(6):954-64. Review.

PMID:
12788434
19.

Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease.

Lowy AM, Lee JE, Pisters PW, Davidson BS, Fenoglio CJ, Stanford P, Jinnah R, Evans DB.

Ann Surg. 1997 Nov;226(5):632-41. Review.

20.

[Prevention of pancreatic fistula after cephalic duodenopancreatectomy].

Sauvanet A, Belghiti J.

Ann Chir. 1999;53(7):612-7. Review. French.

PMID:
10520501

Supplemental Content

Support Center